Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NightHawk Begins Work on Mfg. Agreement for Leading University | Contract Pharma

What are you searching for?

Sign in
Breaking News

NightHawk Begins Work on Mfg. Agreement for Leading University

Scorpius subsidiary to manufacture novel biologic targeting substance use disorder.

By: Anthony Vecchione

NightHawk Biosciences, an integrated contract development and manufacturing organization (CDMO), reported that Scorpius BioManufacturing has commenced work on a contract that it was awarded by a leading university to develop and manufacture a novel biologic targeting substance use disorder, which includes drug, alcohol, and opioid addiction.

Jeff Wolf, CEO of NightHawk, said, “We are honored to have been awarded this multi-million-dollar contract by one of the foremost research universities in the United States. Scorpius was selected due to its process development and large molecule manufacturing expertise, as well as its flexibility and dedication to customer service. We are off to a strong start and look forward to expanding this relationship into additional programs in 2024 and beyond. Overall, we could not be more excited by the traction and growing pipeline within Scorpius.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics